Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study

Background: There is a lack of biochemical markers for early prediction of relapse in patients with Graves' disease [GD], which may help to direct treatment decisions. We assessed the prognostic ability of a high-throughput proton NMR metabolomic profile to predict relapse in a well characteriz...

Full description

Bibliographic Details
Main Authors: Tristan Struja, Andreas Eckart, Alexander Kutz, Andreas Huber, Peter Neyer, Marius Kraenzlin, Beat Mueller, Christian Meier, Luca Bernasconi, Philipp Schuetz
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2018.00623/full